CATEGORY · PRIVATE MEDICAL SEARCH
Private Medical Search
Private medical search is what happens when a hospital takes the search experience clinicians already get from OpenEvidence and UpToDate Expert AI — and constrains it to its own local data: chart-grounded patient context, hospital-curated guidelines, the formulary, the literature subset the institution licenses, and approved external evidence sources. Same speed. Cite-grounded. Inside the walls. This guide is the buyer's view of what the category does, what the published evidence shows, the hybrid retrieval design that actually works, and where Canadian residency rules turn the cloud option into a non-starter.
Consultations per month as of January 2026 across 757,000+ verified U.S. physicians. The market reference point for what "AI medical search" feels like to clinicians today.
Monthly visits to UpToDate's AI-enabled search interface (launched mid-2025). Roughly one third of total UpToDate traffic — clinicians have already shifted preferences within months of release.
OpenEvidence accuracy on complex subspecialty scenarios in a December 2025 preprint (34% Quick Consult, 41% Deep Consult). Same product scores 100% on USMLE-style questions — complexity matters.
Issued by the Commission d'accès à l'information in Q1 2026 alone under Section 91. Cloud-based AI processing of health data is now treated as presumptively non-compliant in several Canadian provinces without province-resident infrastructure.
How "private medical search" differs from public AI search
OpenEvidence and UpToDate Expert AI are the public reference for what a clinician feels when they ask a medical question and get a cited synthesis in seconds. Both products are excellent for what they do — return synthesized answers from licensed clinical literature. What they don't do, and cannot do, is reason over your hospital's local guidelines, your formulary, your patient's chart, or your internal SOPs. They also don't run inside your hospital network.
Private medical search is the local-first analog. The corpus is hospital-curated: licensed clinical literature where applicable, plus internal clinical guidelines, formulary, care pathways, EHR-grounded patient context, and an approved subset of public references (PubMed, evidence-grade summaries). The retrieval respects the user's permissions. The inference happens inside the hospital network. The audit trail lives in the hospital's data center.
Why search, not just Q&A
Private medical search overlaps with document Q&A but emphasizes a different surface: clinicians often want a list of relevant evidence to skim before they commit to a synthesized answer. The search modality preserves clinician judgment — surfacing the top ten relevant references with one-line summaries lets the user pick, dismiss, and cross-check, which is the workflow many clinicians prefer over a pre-synthesized paragraph. Document Q&A and private medical search share infrastructure, but they are different UIs over the same retrieval layer:
Ranked list of cited passages, each with the source, version stamp, and one-line gloss. Clinician picks. Closest to UpToDate Search or PubMed but on hospital-controlled corpora.
Cited synthesis paragraph drawn from the retrieval set, with claim-level source linking. Closest to OpenEvidence DeepConsult or UpToDate Expert AI but on hospital-controlled corpora.
Same retrieval layer, scoped to the active patient. "What does our local sepsis pathway recommend for this patient given creatinine 2.1 and weight 92 kg?" Returns retrieved passages plus the patient parameters that drove the filter.
Queries span internal guidelines, formulary, SOP library, and approved external evidence sources. Surface contradictions when local pathway diverges from external guideline — that conflict is itself the clinical value.
The retrieval architecture that works in 2026
The 2025–2026 healthcare RAG literature converged on a pattern that consistently outperforms naive vector retrieval on medical tasks. The shape worth copying:
- checkHybrid retrieval: BM25 + dense embeddings. Sparse retrieval (BM25) is essential for exact biomedical entity match — ICD-10 codes, drug names, dosages. Dense retrieval covers synonyms and concept-level matches. The published consensus for clinical decision support is balanced ~50/50 weighting; tune per corpus.
- checkDomain-tuned embeddings. PubMedBERT has the strongest documented retrieval performance on medical literature; MedEmbed and MedEIR are credible specialized alternatives. Validate against BLURB or MIMIC-III before committing.
- checkKnowledge graph for structure and audit. Hybrid pipelines that combine BM25 + dense retrieval + a clinical knowledge graph (frameworks like MEDRAG, CliniqIR in the literature) consistently outperform either side alone — and the graph layer enforces structured access control, lineage, and audit, which a pure vector store cannot.
- checkSelf-RAG / multi-evidence refinement. Generate, list uncited claims, refine using cited passages only. MEGA-RAG (Frontiers in Public Health, 2025) reduced hallucinations by >40% over baseline RAG on health-question benchmarks using this pattern.
- checkPermission-aware filtering. The user's access scope filters the candidate retrieval set before the LLM sees it. Otherwise the model can paraphrase content the user is not authorized to read.
- checkCitations carry version stamps. Every cited passage shows the document version it came from. Stale-but-correct-looking answers erode clinician trust faster than wrong ones.
What goes wrong
- closeNaive RAG degrades performance. The 2025 PLOS Digital Health systematic review on RAG in healthcare is direct: standard RAG can produce modest factuality drops and pronounced completeness drops in GPT-4o and Llama-3.1-8B. Naive retrieval is worse than no retrieval on some medical tasks. The investment is in the retrieval design, not in plugging a vector store into a chat UI.
- closeSubspecialty cliffs. Even the best public AI search shows large accuracy drops on complex subspecialty scenarios — the December 2025 OpenEvidence preprint reported 34–41% on subspecialty cases versus 100% on USMLE-style. Plan for this with specialty-by-specialty evaluation, not a single accuracy number.
- closeCross-border data exposure. Cloud AI processing of health data is now treated as presumptively non-compliant under Ontario PHIPA Section 55, Alberta HIA Section 60, BC FIPPA Section 30.1, and Quebec Law 25 Article 17 — without province-resident infrastructure. The Commission d'accès à l'information du Québec issued C$2.3M in fines in Q1 2026 alone. Vendor attestation is no longer a sufficient defense.
- closeConfident-but-wrong synthesis. Same risk as document Q&A: the model paraphrases a passage just enough to alter meaning while keeping the citation. Mitigation: extractive answers for high-stakes questions, abstractive only when retrieval is high-confidence and citations cover every claim.
- closeUnbounded scope creep. "Search everything" attempts collapse under maintenance. The published implementation literature is unanimous: bounded corpus per pilot, one user group, one workflow, then expand.
The evaluation rubric that survives the demo
Of the top-k passages, how many are relevant. The number that determines whether the synthesis layer has signal to reason over.
Percentage of factual claims with a verifiable source. Aim for ≥95% on policy-grounded queries; treat anything below as not production-ready.
Don't accept a single accuracy number. Slice by specialty. The OpenEvidence subspecialty cliff is the warning shot — your corpus has a similar shape.
Audit a sample for cases where retrieval surfaced (or paraphrased) content the user was not authorized to see. Anything > 0% requires fix.
Time from policy or guideline update to index reflection. Express as a service-level objective. Typical target: under 24 hours for high-traffic corpora.
Median end-to-end response time. Below 2 seconds for search-style; below 5 seconds for synthesis-style. Above that, clinicians revert to the intranet.
Reconstruct retrieved passages, generated synthesis, and clinician follow-up for any historical query. Required by the 2026 HIPAA Security Rule update and by provincial residency rules in Canada.
Cases where the system retrieved contradicting evidence (local pathway vs. external guideline) and surfaced the conflict. Higher is better — that's where the clinical value lives.
Cloud commercial vs. on-prem — the architecture choice
Public AI search products (OpenEvidence, UpToDate Expert AI) are excellent for what they do and have a real adoption story among U.S. clinicians. They do not solve private medical search, because the corpus they reason over is not yours. The architectural choice for hospital-internal corpora:
| Dimension | Public AI search (OpenEvidence, UpToDate AI) | Cloud RAG vendor | On-prem (WalledCare) |
|---|---|---|---|
| Corpus | Vendor-licensed evidence library | Customer documents, indexed in vendor cloud | Customer documents, indexed inside hospital network |
| Patient-grounded queries | Not supported | Limited (no native EHR integration in most cases) | FHIR-grounded retrieval against the live EHR |
| Residency posture | U.S. cloud | U.S. cloud unless tenanted regionally | Province-resident, no outbound API |
| Permission model | Per-clinician licensing only | Customer maps SSO + role into vendor model | Native filter against the customer directory |
| Embedding model | Vendor-chosen, opaque | Vendor-chosen, partially configurable | Domain-tuned (PubMedBERT, MedEmbed); swappable |
| Audit | Vendor-side; limited customer access | Vendor-side; API-exposed | Append-only inside the hospital data center |
| Conflict surfacing (local vs. external) | External-only — no local context to contradict | Possible, depends on integration depth | Native: local pathway and external evidence in the same retrieval layer |
For most hospitals, the full answer is "both": clinicians keep their public AI search subscription for general medical questions, and the institution stands up an on-prem private medical search layer for everything that touches local guidelines, formulary, patient context, and SOPs. The two are complementary surfaces, not competitors.
Canadian residency in particular
Healthcare buyers in Canada now operate under a tighter set of constraints than at any point in the previous decade. The published 2026 enforcement signal:
- checkQuebec Law 25 Article 17 requires Quebec residency for sensitive personal information. Cloud AI processing constituting a "communication" of personal information triggers Section 17. C$2.3M in fines issued in Q1 2026 alone.
- checkOntario PHIPA Section 55 and Alberta HIA Section 60 require explicit consent or comparable protection for cross-border transfers — and U.S. CLOUD Act exposure is now treated as not satisfying the standard.
- checkBC FIPPA Section 30.1 imposes data-residency expectations on public bodies, including most public hospitals.
- checkEncryption with Canadian-controlled keys is the practical safeguard cited by compliant programs — neither vendor attestation alone nor U.S.-managed keys are sufficient under provincial enforcement standards.
For a Canadian hospital, "private medical search" is therefore not a preference — it is a regulatory floor. A cloud RAG vendor processing health data in a U.S. region cannot satisfy the residency requirement regardless of contractual safeguards. Province-resident infrastructure with customer-controlled keys is the configuration that survives a CAI or IPC audit in 2026.
How this fits into a multi-app local stack
Private medical search and document Q&A share a retrieval layer. The same layer can ground specialty templates for an ambient scribe, source patient-instruction language for discharge summaries, and back the runbook lookups inside handoff tools. The compounding effect of building a single, well-instrumented on-prem retrieval layer is the architectural reason a multi-app local stack outperforms five separate cloud vendors on TCO and audit posture.
Pick a corpus, run a real pilot
The shortest path to a defensible private medical search decision is to scope one bounded corpus — typically the local clinical guideline library or the formulary plus stewardship policy — define the rubric above, and run the pilot against a cloud RAG vendor (where one is realistic for the corpus) and an on-prem reference stack. The differences appear in citation coverage, permission leakage, freshness, and conflict surfacing — exactly where vendor demos cannot answer.
send Request a WalledCare pilot arrow_back Back to directory
Further reading
- OpenEvidence to augment clinical decision-making for primary care physicians (PMC, 2025)
- Accuracy and repeatability of OpenEvidence on subspecialty scenarios (medRxiv preprint, Dec 2025)
- OpenEvidence $210M Series B at $3.5B valuation
- STAT: UpToDate launches Expert AI to answer clinical questions
- MEGA-RAG: hallucination mitigation in public-health RAG (Frontiers, 2025)
- PLOS Digital Health: Systematic review of RAG for LLMs in healthcare (2025)
- arXiv: Retrieval-augmented generation in biomedicine
- EHR-oriented knowledge graph system for collaborative CDS
- Hybrid RAG: graphs, BM25, and the end of black-box retrieval
- MedEmbed: fine-tuned embedding models for medical IR
- MedEIR: specialized medical embedding model
- Canadian data sovereignty in 2026 — what changed
- Quebec Law 25 and AI: 2026 compliance guide
- Law 25 compliance checklist for AI tools (2026)
- Quebec Law 25 compliance guide — deadlines, key steps
- WalledCare: On-premise clinical assistants reference stack